Marijuana Users Could Stop Effects Of Acomplia

When Acomplia first began to be talked about as a weight loss remedy much was made of the fact that it worked on the same cannabioid receptors that marijuana works on. The only difference is that with marijuana the effect on the cannabioid receptors is directly the opposite to that of Acomplia or rimonabant. For those people who have ever smoked a joint they know that the high that comes with it is often followed by 'the munchies' namely an extreme desire to eat anything. 

Acomplia works the opposite way by depressing the appetite of the obese people who are prescribed it and by actually blocking the cannabinoid receptors in the brain, incidentally the same cannaboid receptors that aggravate hunger pangs when people absorb the THC which comes in marijuana. The big question that people are asking is what will happen to those people who smoke cannabis and also use Acomplia? Will the THC in the marijuana or the rimonabant in the Acomplia win in the battle for control of the cannibinoid receptors?

The Editor of the Journal for the California Cannabis Research Medical Group was recently quoted as saying that he had been at the AGM of the International Cannabinoid Research Society and this exact dilemma was posed to the representative of Sanofi-Aventis who make the weight loss drug Acomplia and who were sponsoring the conference.

It appears however that the Acomplia drug was never tested with marijuana and so the effect of both of them together has yet to be properly evaluated and checked.  The use of marijuana under controlled conditions for people who suffer from chronic pain is allowed in the United States if a doctor approves the use of it and there are concerns that these people may also be prescribed Acomplia. It may be that people who use marijuana may need bigger doses of the Acomplia than normal as there will be different drugs working on the same receptor sites.